ArticleBreast cancer research and treatment2026

Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapy.

Rebecca Pedersini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.